** CStone Pharmaceuticals 2616.HK slides 13% to HK$3, lowest since February 25
** Stock set for biggest one-day pct decline since March 7, 2024; top pct loser on Hong Kong bourse
** Chinese biopharma developer plans to sell 80 mln new shares to third party investors to raise HK$234.6 mln ($30.2 mln) for R&D and general corporate purposes
** Says shares will be issued at HK$2.933, representing ~15% discount to Tuesday's close of HK$3.45
** Stock gains 30.4% YTD
($1 = HK$7.7808)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。